Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Efforts to Improve Quality of Migraine Medical Care
Release Date:
Partner: The Japanese Headache Society
Review Process: Expert Review Panel
Translation: Japanese (link)
Education Internal Medicine Japan
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Shared Decision-Making (SDM) in Lung Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Improving the Therapeutic Environment for Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Gene and Gene-modified Cell Therapies Medical Education
Release Date:
Partner: American Society of Gene + Cell Therapy
Review Process: Expert Review Panel
Education Rare Disease All
New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
Release Date:
Partner: Arvinas
Review Process: Pfizer Internal
Education Oncology All
Sickle Cell Disease (SCD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient Education
Release Date:
Review Process: Pfizer Internal
Education Oncology Ghana, Rwanda
2023 Oncology Fellowship
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Fellowship Oncology Canada
Emerging Science in the Management of Acute Myeloid Leukemia
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Juvenile Idiopathic Arthritis (JIA) Patient Education
Release Date:
Review Process: Expert Review Panel
Education Inflammation & Immunology USA
An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Education Inflammation & Immunology All
PARP-inhibitor Combination Treatments in Prostate Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology China
Addressing Educational Barriers to Equitable Care for Patients with Immune Inflammatory Diseases
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient Care
Release Date:
Review Process: Pfizer Internal
Quality Improvement Support for the Professions Senegal
Increasing Understanding of the Evolving Hemophilia Treatment Landscape
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Improving cancer care in patients with metastatic breast cancer
Release Date:
Review Process: Pfizer Internal
Translation: (link)
Translation: (link)
Quality Improvement Oncology Kazakhstan
Updates in Post-COVID Conditions: Potential Causes, Assessment, Testing, Management, and Ongoing Research
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Bridging the Inflammatory Dermatosis Care Divide with Teledermatology
Release Date:
Partner: The George Washington University
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology USA